Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05662306 · ClinicalTrials.gov registry record · Phase 4
C-Cog in Early Course Schizophrenia Study
A Phase 4 study, sponsored by University of Miami.
- Terminated
- Registry status
- Phase 4
- Development phase
- 1
- Enrollment target
NCT05662306: Clinical Trial Phase 4 study, sponsored by University of Miami.
NCT05662306 is a Phase 4 study that was terminated before completion, run by University of Miami. The registered enrollment target is 1 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05662306, a Phase 4 study, was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the role of clinical stability in functional recovery. in first episode schizophrenia.
Primary Outcome
PANSS has 6 critical items with each item being scored from 1 to 7 with the higher score indicating more severe symptoms. A score of 3 or less on all six critical items defines the presence of remission.
Interventions
- DRUG Aripiprazole Lauroxil
- BEHAVIORAL Computerized cognitive and functional skills training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2024-01-23 |
| Est. Completion | 2025-03-03 |
| Phase | Phase 4 |
Why NCT05662306 stopped before completion
NCT05662306 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Aripiprazole Lauroxil is the first listed.
NCT05662306 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05662306 about?
NCT05662306 is a clinical study titled "C-Cog in Early Course Schizophrenia Study". The purpose of this study is to examine the role of clinical stability in functional recovery. in first episode schizophrenia.
What is the current status of trial NCT05662306?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 1 participants. The study started on 2024-01-23. Estimated completion is 2025-03-03.
What interventions are being tested in trial NCT05662306?
The interventions under investigation include: Aripiprazole Lauroxil (DRUG), Computerized cognitive and functional skills training (BEHAVIORAL).
Who is sponsoring clinical trial NCT05662306?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05662306's enrollment target sits among peer trials
1 2000th of 2000 the lowest of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI